After the FDA placed two of its next-gen HIV drugs on clinical hold last June, Gilead Sciences has now terminated one of the ...
We intend to fully fund this program.” By Stephen Simpson, The Texas Tribune Texas is launching its own research program into ...
A groundbreaking gene therapy developed through a UCLA-led clinical trial has received approval from the U.S. Food and Drug ...
The FDA has approved a drug for patients who are 12 and older with classical Hodgkin lymphoma based on the results of a ...
Last year, state lawmakers set aside $50 million for research into the psychoactive drug, which can treat opioid withdrawal ...
Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) (FRA: 0K91) (“Quantum BioPharma” or the “Company”), a biopharmaceutical company dedicated to building a portfolio of innovative assets and biotech ...
Novo Nordisk’s icodec-abae is now approved in the US for type 2 diabetes only, after a prior rejection partly due to concerns about hypoglycemia in type 1 diabetes.
Treprostinil is a potent drug for various lung diseases because it opens blood vessels, reduces lung scarring, inhibits ...
The FDA wants to know more about mobile-enabled clinical trials for investigational drugs. According to a recent post on the Federal Register by Associate Commissioner for Policy Leslie Kux, the FDA ...
Use of the psychoactive substance has shown promise in helping those suffering from PTSD and opioid withdrawal symptoms. A ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results